ID: ALA5274909

Max Phase: Preclinical

Molecular Formula: C59H80N8O14

Molecular Weight: 1125.33

Associated Items:

Representations

Canonical SMILES:  COC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CCCOc1ccc2ccc(OCCCC(=O)N[C@H](CCCCNC(=O)OCc3ccccc3)C(=O)NNC(=O)c3cc(NC(C)=O)ccc3OC)cc2c1)C(C)C)C(C)C

Standard InChI:  InChI=1S/C59H80N8O14/c1-36(2)31-48(55(72)65-53(38(5)6)58(75)78-9)63-57(74)52(37(3)4)64-51(70)21-16-30-80-45-26-23-41-22-25-44(32-42(41)33-45)79-29-15-20-50(69)62-47(19-13-14-28-60-59(76)81-35-40-17-11-10-12-18-40)56(73)67-66-54(71)46-34-43(61-39(7)68)24-27-49(46)77-8/h10-12,17-18,22-27,32-34,36-38,47-48,52-53H,13-16,19-21,28-31,35H2,1-9H3,(H,60,76)(H,61,68)(H,62,69)(H,63,74)(H,64,70)(H,65,72)(H,66,71)(H,67,73)/t47-,48+,52+,53+/m1/s1

Standard InChI Key:  BMSVVWNFMADEMG-WCQONJCXSA-N

Associated Targets(non-human)

Human immunodeficiency virus type 1 protease 9113 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 1125.33Molecular Weight (Monoisotopic): 1124.5794AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Ghosh AK, Osswald HL, Prato G..  (2016)  Recent Progress in the Development of HIV-1 Protease Inhibitors for the Treatment of HIV/AIDS.,  59  (11): [PMID:26799988] [10.1021/acs.jmedchem.5b01697]

Source